The DOI matches its Crossref record; the references it cites are not checked yet.
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Published version of a preprint
Abstract
Emerging evidence has highlighted the host immune system in modulating the patient response to chemotherapy, but the mechanism of this modulation remains unclear. The aim of this study was to analyze the effect of chemotherapy on antitumor immunity in the tumor microenvironment of ovarian cancer. Treatment of ovarian cancer cell lines with various chemotherapeutic agents resulted in upregulated expression of MHC class I and programmed cell death 1 ligand 1 (PD-L1) in a NF-κB-dependent manner and suppression of antigen-specific T-cell function in vitro. In a mouse model of ovarian cancer, treatment with paclitaxel increased CD8(+) T-cell infiltration into the tumor site, upregulated PD-L1 expression, and activated NF-κB signaling. In particular, tumor-bearing mice treated with a combination of paclitaxel and a PD-L1/PD-1 signal blockade survived longer than mice treated with paclitaxel alone. In summary, we found that chemotherapy induces local immune suppression in ovarian cancer through NF-κB-mediated PD-L1 upregulation. Thus, a combination of chemotherapy and immunotherapy targeting the PD-L1/PD-1 signaling axis may improve the antitumor response and offers a promising new treatment modality against ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several chemotherapeutic agents have also been shown to increase the expression of PD-L1”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Peng et al., 2015
Citations
Fetching the citation lists
Reading what this paper cites and what cites it from the registries. The lists appear here in a minute or two.
References 52 · Cited by 525
Research works printed but not linked: 1
- Carlsson, 2014, PD-L1, Inflammation and Glioblastoma, J Immunol Clin Res, 2, 1013
Metadata
- Authors
- Peng, J., Hamanishi, J., Matsumura, N., Abiko, K., Murat, K., Baba, T., Yamaguchi, K., Horikawa, N., Hosoe, Y., Murphy, S. K., Konishi, I., & Mandai, M.
- Affiliations
- Kyoto University (JP)
- Duke University (US)
- Kindai University (JP)
- ORCID
- Venue
- Cancer Research
- Published
- 2015-11-30
- Volume
- 75
- Issue
- 23
- Pages
- 5034-5045
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2177804157
- Cited by
- 525
- References
- 52
- Citations by year
- 2026: 19 · 2025: 43 · 2024: 30 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 68 · 2019: 68 · 2018: 51 · 2017: 32 · 2016: 22
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ono Pharmaceutical
- Japan Society for the Promotion of Science (26293359, 26670723)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- ovarian cancer, chemotherapy, PD-L1, NF-κB signaling, tumor microenvironment, immunosuppression, MHC class I, paclitaxel, PD-1/PD-L1 blockade, CD8+ T cells, antitumor immunity, combination therapy
- MeSH terms
- Capecitabine, Docetaxel, Animals, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Organoplatinum Compounds, Ovarian Neoplasms, NF-kappa B, Xenograft Model Antitumor Assays, Taxoids, Cell Line, Tumor, Mice, Tumor Microenvironment, Transcriptome, B7-H1 Antigen, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-3098
- The paper
- Peng, J., Hamanishi, J., Matsumura, N., Abiko, K., Murat, K., Baba, T., Yamaguchi, K., Horikawa, N., Hosoe, Y., Murphy, S. K., Konishi, I., & Mandai, M. (2015). Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-3098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.